Chung KJ - Search Results

1

In-depth analysis of cysteine oxidation by the RBC proteome: advantage of peroxiredoxin II knockout mice.

Yang HY, Kwon J, Choi HI, Park SH, Yang U, Park HR, Ren L, Chung KJ, Kim YU, Park BJ, Jeong SH, Lee TH. Yang HY, et al. Among authors: chung kj. Proteomics. 2012 Jan;12(1):101-12. doi: 10.1002/pmic.201100275. Epub 2011 Dec 2. Proteomics. 2012. PMID: 22113967

2

Proteomic analysis of protein expression affected by peroxiredoxin V knock-down in hypoxic kidney.

Yang HY, Kwon J, Cho EJ, Choi HI, Park C, Park HR, Park SH, Chung KJ, Ryoo ZY, Cho KO, Lee TH. Yang HY, et al. Among authors: chung kj. J Proteome Res. 2010 Aug 6;9(8):4003-15. doi: 10.1021/pr100190b. J Proteome Res. 2010. PMID: 20553050

3

Comparative proteomic analysis for the insoluble fractions of colorectal cancer patients.

Yang HY, Kwon J, Park HR, Kwon SO, Park YK, Kim HS, Chung YJ, Chang YJ, Choi HI, Chung KJ, Lee DS, Park BJ, Jeong SH, Lee TH. Yang HY, et al. Among authors: chung kj, chung yj. J Proteomics. 2012 Jun 27;75(12):3639-53. doi: 10.1016/j.jprot.2012.04.018. Epub 2012 Apr 30. J Proteomics. 2012. PMID: 22564821

4

The role of peroxiredoxin III on late stage of proerythrocyte differentiation.

Yang HY, Jeong DK, Kim SH, Chung KJ, Cho EJ, Yang U, Lee SR, Lee TH. Yang HY, et al. Among authors: chung kj. Biochem Biophys Res Commun. 2007 Aug 10;359(4):1030-6. doi: 10.1016/j.bbrc.2007.06.007. Epub 2007 Jun 11. Biochem Biophys Res Commun. 2007. PMID: 17574212

5

Gene expression profiling related to the enhanced erythropoiesis in mouse bone marrow cells.

Yang HY, Jeong DK, Kim SH, Chung KJ, Cho EJ, Jin CH, Yang U, Lee SR, Lee DS, Lee TH. Yang HY, et al. Among authors: chung kj. J Cell Biochem. 2008 May 1;104(1):295-303. doi: 10.1002/jcb.21620. J Cell Biochem. 2008. PMID: 17990289

6

The role of peroxiredoxin V in (-)-epigallocatechin 3-gallate-induced multiple myeloma cell death.

Ren L, Yang HY, Choi HI, Chung KJ, Yang U, Lee IK, Kim HJ, Lee DS, Park BJ, Lee TH. Ren L, et al. Among authors: chung kj. Oncol Res. 2011;19(8-9):391-8. doi: 10.3727/096504011x13127606672922. Oncol Res. 2011. PMID: 22329198

7

Peroxiredoxin V selectively regulates IL-6 production by modulating the Jak2-Stat5 pathway.

Choi HI, Chung KJ, Yang HY, Ren L, Sohn S, Kim PR, Kook MS, Choy HE, Lee TH. Choi HI, et al. Among authors: chung kj. Free Radic Biol Med. 2013 Dec;65:270-279. doi: 10.1016/j.freeradbiomed.2013.06.038. Epub 2013 Jul 3. Free Radic Biol Med. 2013. PMID: 23831231 Free article.

8

RtxA1-induced expression of the small GTPase Rac2 plays a key role in the pathogenicity of Vibrio vulnificus.

Chung KJ, Cho EJ, Kim MK, Kim YR, Kim SH, Yang HY, Chung KC, Lee SE, Rhee JH, Choy HE, Lee TH. Chung KJ, et al. Among authors: chung kc. J Infect Dis. 2010 Jan 1;201(1):97-105. doi: 10.1086/648612. J Infect Dis. 2010. PMID: 19919301

9

Microglial peroxiredoxin V acts as an inducible anti-inflammatory antioxidant through cooperation with redox signaling cascades.

Sun HN, Kim SU, Huang SM, Kim JM, Park YH, Kim SH, Yang HY, Chung KJ, Lee TH, Choi HS, Min JS, Park MK, Kim SK, Lee SR, Chang KT, Lee SH, Yu DY, Lee DS. Sun HN, et al. Among authors: chung kj. J Neurochem. 2010 Jul;114(1):39-50. doi: 10.1111/j.1471-4159.2010.06691.x. Epub 2010 Mar 20. J Neurochem. 2010. PMID: 20345759 Free article.

10

Major ABO Incompatibility in Non-Myeloablative Hematopoietic Stem Cell Transplant for Sickle Cell Disease-Not an Insurmountable Obstacle.

Chung KJE, Wall DA, Chiang KY. Chung KJE, et al. Pediatr Blood Cancer. 2025 Jan 9:e31515. doi: 10.1002/pbc.31515. Online ahead of print. Pediatr Blood Cancer. 2025. PMID: 39788912

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters